某院普外科围手术期止血药物的使用分析  

The Analysis of Hemostatic Medicine in General Surgery in A Hospital

作　　者：刘晓敏[1] 刘广洲[2] 石丽霞[1] 张雷[1] 

机构地区：[1]吉林医药学院附属医院,吉林吉林132013 [2]吉林市高新区华侨医院,吉林吉林132000

出　　处：《中国医药指南》2016年第32期4-6,共3页Guide of China Medicine

摘　　要：目的了解某院普外科止血药物在围手术期的应用情况,规范外科手术止血药物的使用。方法调取某院2013年普外科出院手术患者病例,共计200份。结合大量文献以及实际临床疗效,对该院普外科围手术期止血药物的应用数据进行调查、统计和分析。结果在调查的200例手术患者中,有175例应用止血药物,占87.50%。应用最多的止血药物是蛇毒血凝酶,使用比例为74.86%;≥60岁应用止血药的患者占用药总人数的比例最高,为28.57%;胆囊切除术患者用药比例最高,为98.33%,占用药总人数的33.70%。结论普外科围手术期止血药物种类选择基本合理,但在用药指征和首次用药时间方面存在不合理现象,应进一步规范止血药物应用,使围手术期止血药物使用更加合理,手术患者用药更加安全。Objective To investigate the Hemostatic medicine used in general surgery during perioperative period and to standardize the use of surgical hemostatic medicine. Methods 200 cases of the general surgery in 2013 were statisticsed and analysised by Combining with a large number of literature and actual clinical curative effect. Results 175 cases（87.50%） used hemostatic medicine during perioperative period. Among all of the different medicines, the snake venom blood clotting enzyme was used more often, the using ratio was 74.86%. The patients over 60 years old used medicine more often than younger patients（the ration is 28.57%）. 98.33% of the cholecystectomy patients used hemostatic medicine. Conclusion Hemostatic medicine are nessessary for the patient during surgery. The criterion for hemostatic medicine, such as when to use and how much to use, needs further study. The standardized procedure will benefit all patients in future.

关 键 词：普外科 围手术期 止血药物 合理用药 

分 类 号：R973.1[医药卫生—药品] R969.3[医药卫生—药学]